Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia.

Künkele A, Grosse-Lordemann A, Schramm A, Eggert A, Schulte JH, Bachmann HS.

BMC Cancer. 2013 Oct 2;13:452. doi: 10.1186/1471-2407-13-452.

2.

Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.

Cingeetham A, Vuree S, Dunna NR, Gorre M, Nanchari SR, Edathara PM, Meka P, Annamaneni S, Digumarthi R, Sinha S, Satti V.

Tumour Biol. 2015 Sep;36(10):7967-76. doi: 10.1007/s13277-015-3457-4. Epub 2015 May 10.

PMID:
25957891
3.

The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.

Bachmann HS, Otterbach F, Callies R, Nückel H, Bau M, Schmid KW, Siffert W, Kimmig R.

Clin Cancer Res. 2007 Oct 1;13(19):5790-7.

4.

Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.

Stamati L, Avgeris M, Kosmidis H, Baka M, Anastasiou T, Piatopoulou D, Scorilas A, Gourgiotis D.

J Cancer Res Clin Oncol. 2015 Nov;141(11):2023-36. doi: 10.1007/s00432-015-1982-6. Epub 2015 May 16.

PMID:
25982455
5.

Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme.

El Hindy N, Bachmann HS, Lambertz N, Adamzik M, Nückel H, Worm K, Zhu Y, Sure U, Siffert W, Sandalcioglu IE.

J Neurosurg. 2011 Jun;114(6):1631-9. doi: 10.3171/2010.12.JNS10478. Epub 2011 Jan 21.

PMID:
21250804
6.

The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma.

Lehnerdt GF, Franz P, Bankfalvi A, Grehl S, Kelava A, Nückel H, Lang S, Schmid KW, Siffert W, Bachmann HS.

Ann Oncol. 2009 Jun;20(6):1094-9. doi: 10.1093/annonc/mdn763. Epub 2009 Feb 5.

PMID:
19196738
7.

Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.

Bhushann Meka P, Jarjapu S, Vishwakarma SK, Nanchari SR, Cingeetham A, Annamaneni S, Mukta S, Triveni B, Satti V.

Tumour Biol. 2016 May;37(5):6905-12. doi: 10.1007/s13277-015-4554-0. Epub 2015 Dec 11.

PMID:
26662799
8.

DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia.

Zhao XQ, Cao WJ, Yang HP, Yang XW, Tang P, Sun L, Gao X.

Tumour Biol. 2016 Aug;37(8):10393-402. doi: 10.1007/s13277-016-4908-2. Epub 2016 Feb 4.

PMID:
26846104
9.

Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.

Gagné V, Rousseau J, Labuda M, Sharif-Askari B, Brukner I, Laverdière C, Ceppi F, Sallan SE, Silverman LB, Neuberg D, Kutok JL, Sinnett D, Krajinovic M.

Clin Cancer Res. 2013 Sep 15;19(18):5240-9. doi: 10.1158/1078-0432.CCR-13-1215. Epub 2013 Aug 1. Erratum in: Clin Cancer Res. 2014 Aug 15;20(16):4415.

10.

Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.

Nückel H, Frey UH, Bau M, Sellmann L, Stanelle J, Dürig J, Jöckel KH, Dührsen U, Siffert W.

Blood. 2007 Jan 1;109(1):290-7. Epub 2006 Sep 7.

11.

The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.

Hirata H, Hinoda Y, Nakajima K, Kikuno N, Suehiro Y, Tabatabai ZL, Ishii N, Dahiya R.

J Urol. 2009 Aug;182(2):721-7. doi: 10.1016/j.juro.2009.03.081. Epub 2009 Jun 18.

PMID:
19539330
12.

Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.

Tantawy AA, El-Bostany EA, Adly AA, Abou El Asrar M, El-Ghouroury EA, Abdulghaffar EE.

Blood Coagul Fibrinolysis. 2010 Jan;21(1):28-34. doi: 10.1097/MBC.0b013e32833135e9. Erratum in: Blood Coagul Fibrinolysis. 2010 Mar;21(2):200.

PMID:
19923983
13.

Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.

Uckun FM, Yang Z, Sather H, Steinherz P, Nachman J, Bostrom B, Crotty L, Sarquis M, Ek O, Zeren T, Tubergen D, Reaman G, Gaynon P.

Blood. 1997 May 15;89(10):3769-77.

14.

Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma.

Bachmann HS, Heukamp LC, Schmitz KJ, Hilburn CF, Kahl P, Buettner R, Nückel H, Eisenhardt A, Rübben H, Schmid KW, Siffert W, Eggert A, Schramm A, Schulte JH.

Int J Cancer. 2011 Nov 15;129(10):2390-9. doi: 10.1002/ijc.25904. Epub 2011 Mar 25.

15.

Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancer.

Heubner M, Wimberger P, Otterbach F, Kasimir-Bauer S, Siffert W, Kimmig R, Nückel H.

Int J Biol Markers. 2009 Oct-Dec;24(4):223-9.

PMID:
20082279
16.

Prediction of outcome by early response in childhood acute lymphoblastic leukemia.

Möricke A, Lauten M, Beier R, Odenwald E, Stanulla M, Zimmermann M, Attarbaschi A, Niggli F, Schrappe M.

Klin Padiatr. 2013 May;225 Suppl 1:S50-6. doi: 10.1055/s-0033-1337964. Epub 2013 May 22.

PMID:
23700057
17.

Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.

Peng Y, Wang L, Qing Y, Li C, Ren T, Li Q, Li M, Zhang S, Shan J, Wang G, Yang Z, Wang D.

Sci Rep. 2015 Dec 10;5:17766. doi: 10.1038/srep17766.

18.

[SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia].

Zhang H, He X, Li J, Wang Y, Wang C, Chen Y, Niu C, Gao P.

Zhonghua Er Ke Za Zhi. 2014 Oct;52(10):770-6. Chinese.

PMID:
25537545
19.

[Comparison of the present and previously used protocol of risk stratification in children with acute lymphoblastic leukemia].

Glodkowska E, Bialas A, Jackowska T.

Med Wieku Rozwoj. 2007 Apr-Jun;11(2 Pt 1):153-8. Polish.

PMID:
17625285
20.

Association of BCL2-938C>A genetic polymorphism with glioma risk in Chinese Han population.

Li W, Qian C, Wang L, Teng H, Zhang L.

Tumour Biol. 2014 Mar;35(3):2259-64. doi: 10.1007/s13277-013-1299-5. Epub 2013 Nov 28.

PMID:
24287948

Supplemental Content

Support Center